| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8750335 | New Microbes and New Infections | 2017 | 6 Pages |
Abstract
A significant proportion of M. tuberculosis was resistant to at least one first line anti-TB drug. Moreover, the frequencies of resistance to either isoniazid or rifampicin were high compared to data that were previously reported in some part of the country.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Z. Bedewi, Y. Mekonnen, A. Worku, G. Medhin, A. Zewde, G. Yimer, R. Pieper, G. Ameni,